Virtual Screening of Substrates and Inhibitors Using Docking

EnzymoGenius™ pioneers virtual screening services, utilizing cutting-edge docking methodologies to predict substrate and inhibitor interactions with unparalleled accuracy. Our service is dedicated to expediting drug discovery and enzyme optimization processes by providing in-depth insights into molecular interactions.

Overview

Virtual screening of substrates and inhibitors through docking is a computational approach employed in drug discovery, particularly in understanding the interaction between biomolecules and potential compounds. Utilizing molecular docking simulations, this method predicts the binding affinity and orientation of ligands within a target protein's active site. Recent research progress in this field has focused on refining the accuracy of predictions by incorporating advanced algorithms and improving scoring functions. Additionally, there has been a growing emphasis on exploring protein dynamics and flexibility to enhance the reliability of virtual screening outcomes. The integration of machine learning techniques has also played a pivotal role in optimizing the screening process, enabling the identification of promising candidates for experimental validation and further development in drug design.

Fig. 1 Docking-based virtual screening and experimental validation. (Neves B J, et al., 2021)

Our Technical Advantages

• High-Throughput Capability
  EnzymoGenius™ excels in handling large-scale virtual screening, providing efficient and rapid analysis of extensive compound libraries.
• Accuracy in Binding Affinity Prediction
  Our service integrates state-of-the-art scoring functions, ensuring accurate prediction of substrate and inhibitor binding affinities.
• Flexible Docking Protocols
  Adaptable docking protocols allow for customization based on specific research needs, optimizing the screening process for diverse applications.

EnzymoGenius™ leverages molecular docking, scoring functions, binding site prediction, and virtual library screening to unravel substrate and inhibitor interactions with unprecedented precision. Our technical advantages lie in high-throughput capability, accurate binding affinity prediction, and flexible docking protocols. With applications spanning drug discovery, enzyme optimization, biochemical pathway analysis, and toxicology studies, our services empower researchers and industries to make informed decisions in their quest for innovative solutions. For tailored virtual screening solutions, contact us to propel your research and drug development endeavors.

Reference

1. Neves, B. J.; et al. Chapter 4-Best Practices for Docking-Based Virtual Screening. Molecular Docking for Computer-Aided Drug Design. 2021, 75-98.